C18H13ClFN3
Neat
325.77
+5°C
Room Temperature
midazolam, 59467-70-8, Buccolam, Midazolamum, 8-Chloro-6-(2-fluorophenyl)-1-methyl-4H-imidazo[1, 5-a][1, 4]benzodiazepine, mezolam, Nayzilam, Midazolam civ, USL261, R60L0SM5BC, USL-261, 8-Chlor-6-(2-fluorphenyl)-1-methyl-4H-imidazo(1, 5-a)(1, 4)benzodiazepin, 8-Chloro-6-(o-fluorophenyl)-1-methyl-4H-imidazo(1, 5-a)(1, 4)benzodiazepine, CHEBI:6931, DTXSID5023320, 4H-Imidazo(1, 5-a)(1, 4)benzodiazepine, 8-chloro-6-(2-fluorophenyl)-1-methyl-, 4H-Imidazo[1, 5-a][1, 4]benzodiazepine, 8-chloro-6-(2-fluorophenyl)-1-methyl-, 8-chloro-6-(2-fluorophenyl)-1-methyl-4h-imidazo(1, 5-a)(1, 4)benzodiazepine, Epistatus, Maleate, Midazolam, 12-chloro-9-(2-fluorophenyl)-3-methyl-2, 4, 8-triazatricyclo(8.4.0.0^(2, 6))tetradeca-1(14), 3, 5, 8, 10, 12-hexaene, 12-chloro-9-(2-fluorophenyl)-3-methyl-2, 4, 8-triazatricyclo[8.4.0.0^{2, 6}]tetradeca-1(14), 3, 5, 8, 10, 12-hexaene, RefChem:6038, Hydrochloride, Midazolam, Midazolam in Sodium Chloride, Midazolam Injection, 10 mg, DTXCID503320, N05CD08, Ro 213981, Ro 21 3981, MIDAZOLAM IN 0.8% SODIUM CHLORIDE, MIDAZOLAM IN 0.9% SODIUM CHLORIDE, 12-chloro-9-(2-fluorophenyl)-3-methyl-2, 4, 8-triazatricyclo(8.4.0.02, 6)tetradeca-1(10), 3, 5, 8, 11, 13-hexaene, 261-774-5, Dormicum, Versed, Midazolamum [INN-Latin], Midazolam Base, DEA No. 2884, Ro 21-3981, CHEMBL655, 8-Chloro-6-(O-fluorophenyl)-1-methyl-4H-imidazo[1, 5-a][1, 4]-benzodiazepine, Dazolam, Midazolam (1.0 mg/mL in methanol), Dormicum (TN), 12-chloro-9-(2-fluorophenyl)-3-methyl-2, 4, 8-triazatricyclo[8.4.0.0^{2, 6}]tetradeca-1(10), 3, 5, 8, 11, 13-hexaene, NCGC00168254-01, EINECS 261-774-5, UNII-R60L0SM5BC, BRN 0625572, Medazolam, Midazolam [USP:INN:BAN:JAN], Buccolam (TN), Nayzilam (TN), 08J, Versed (Salt/Mix), Dormonid (Salt/Mix), Hypnovel (Salt/Mix), Flormidal (Salt/Mix), MIDAZOLAM [INN], MIDAZOLAM [JAN], MIDAZOLAM [MI], MIDAZOLAM [VANDF], Midazolam CRS - * psy, MIDAZOLAM [MART.], MIDAZOLAM [WHO-DD], Midazolam (JAN/USP/INN), SCHEMBL35061, BIDD:GT0647, Midazolam hydrochloride, solid, Midazolam, 1mg/ml in Methanol, GTPL3342, MIDAZOLAM [ORANGE BOOK], MIDAZOLAM CIV [USP-RS], MIDAZOLAM [EP MONOGRAPH], SCHEMBL29357425, SCHEMBL29480459, SCHEMBL29565146, BDBM21363, HSDB 6751, MIDAZOLAM [USP MONOGRAPH], Midazolam 0.1 mg/ml in Methanol, Midazolam 1.0 mg/ml in Methanol, USL261 (nasal spray formulation), HY-B0676, AKOS015842580, DB00683, FM25999, 4H-Imidazo[1, 5-a][1, 4]benzodiazepine, 8-chloro-6-(2-fluoro-phenyl)-1-methyl-, (Z)-2-butenedioate, DB-015270, NS00000476, C07524, D00550, Q423071, Midazolam for system suitability CRS - * psy (Midazolam), Midazolam hydrochloride, United States Pharmacopeia (USP) Reference Standard, 4H-IMIDAZO(1, 5-A)(1, 4)BENZODIAZEPINE and 8-CHLORO-6-(2-FLUOROPHENYL)-1-METHYL
CC1=NC=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4F
8-chloro-6-(2-fluorophenyl)-1-methyl-4H-imidazo[1, 5-a][1 and 4]benzodiazepine
InChI=1S/C18H13ClFN3/c1-11-21-9-13-10-22-18(14-4-2-3-5-16(14)20)15-8-12(19)6-7-17(15)23(11)13/h2-9H,10H2,1H3